Over the past 10 years, the incidence of chronic bronchopulmonary pathology has increased by 21% in relation to the total incidence, while chronic obstructive pulmonary disease is the most common pathology among respiratory diseases (1,2,3,4). Due to the body's reduced immune defenses, patients with COPD have an increased susceptibility to viral infections, including SARS-CoV-2. The prevalence of COPD is higher among patients with more severe forms of COVID-19 (5). The emergence of a new infectious agent has set the challenges for healthcare professionals related to rapid diagnosis and timely provision of medical care to this category of patients (6).

Changes in functional, parameters of spirometry, central hemodynamics

Авдеев C.Н. Системные эффекты у больных ХОБЛ // Врач. 2006. №12. С. 3–8.

Васильева О.С., Гусаков А.А., Гущина Е.Е., Кравченко Н.Ю. Хроническая обструктивная болезнь легких. Пульмонология,- 2013; -№3, -С,49 – 55.

Пульмонология: национальное руководство / под ред. А.Г. Чучалина. М.: ГЭОТАР‑Медиа, 2009. 960 с.

Шуматов В.Б., Невзорова В.А. Клиническая патофизиология системных проявлений хронической обструктивной болезни легких. Владивосток: Медицина ДВ, 2012. 232 с.

Aleva F. E., Voets L., Simons S. O. Prevalence and localization of pulmonary embolism in unexplained acute exacerbations of COPD: a systematic review and meta-analysis // Chest. ‒ 2017. ‒ Vol. 151, № 3. ‒ Р. 544-554

Avdeev S., Moiseev S., Brovko M. et al. Low prevalence of bronchial asthma and chronic obstructive lung disease among intensive care unit patients with COVID-19 // Allergy. ‒ 2020. ‒ Vol. 75, № 10. ‒ Р. 2703-2704.